IndraLab

Statements



reach
"The ability of hVIP and analogues to stimulate cAMP generation paralleled their potencies in displacing 125I-VIP binding."

reach
"(D-Phe2) VIP, VIP [10-28], VIP [16-28], and (p-Cl-D-Phe6, Leu17) VIP, a putative VIP receptor antagonist, affected neither basal cAMP levels nor hVIP induced cAMP accumulation."